Postpartum hemorrhage is associated with one-quarter of all maternal deaths and severe maternal morbidities in the world [1,2]. Uterine atony is the most common underlying condition leading to postpartum hemorrhage [3] and robust evidence indicates that uterotonics used during the third stage of labor are effective in reducing postpartum bleeding [4–6]. Oxytocin has been shown as the most efficacious uterotonic for this indication and the World Health Organization recommends IM/IV oxytocin (10 IU) as the uterotonic drug of choice [7]. Miso-prostol and other injectable uterotonic
Objectives: To identify new and underutilized technologies that may assist in reducing maternal mort...
Ndola Prata, Karen Weidert Bixby Center for Population, Health and Sustainability, School of Public...
Background: Postpartum hemorrhage (PPH) is a major public health problem due to complications that h...
Background: Postpartum hemorrhage (PPH) is a potentially fatal complication of vaginal and cesarean ...
Background:Postpartum hemorrhage (PPH) is a potentially fatal complication of vaginal and cesarean d...
Childbirth is a beautiful and natural process. While in most circumstances, the outcome is good, it ...
Ndola Prata, Suzanne Bell, Karen Weidert Bixby Center for Population, Health and Sustainability, Sch...
Post-partum haemorrhage (PPH) is the most important direct cause of maternal mortality in low resour...
Primary postpartum hemorrhage (PPH) is one of the leading causes of maternal morbidity and mortality...
BackgroundPostpartum hemorrhage (PPH) is the leading cause of maternal death in low-income countries...
Objective: To compare low dose sublingual misoprostol with the standard 10 IU of intramuscular oxyto...
BackgroundA myriad of interventions exist to treat postpartum hemorrhage (PPH), ranging from uteroto...
Postpartum haemorrhage (PPH) remains a major cause of maternal deaths worldwide, and is estimated to...
In contemporary obstetrics, postpartum hemorrhage is one of the primary causes of maternal mortality...
International audienceOBJECTIVE: To evaluate the effectiveness and safety of misoprostol administere...
Objectives: To identify new and underutilized technologies that may assist in reducing maternal mort...
Ndola Prata, Karen Weidert Bixby Center for Population, Health and Sustainability, School of Public...
Background: Postpartum hemorrhage (PPH) is a major public health problem due to complications that h...
Background: Postpartum hemorrhage (PPH) is a potentially fatal complication of vaginal and cesarean ...
Background:Postpartum hemorrhage (PPH) is a potentially fatal complication of vaginal and cesarean d...
Childbirth is a beautiful and natural process. While in most circumstances, the outcome is good, it ...
Ndola Prata, Suzanne Bell, Karen Weidert Bixby Center for Population, Health and Sustainability, Sch...
Post-partum haemorrhage (PPH) is the most important direct cause of maternal mortality in low resour...
Primary postpartum hemorrhage (PPH) is one of the leading causes of maternal morbidity and mortality...
BackgroundPostpartum hemorrhage (PPH) is the leading cause of maternal death in low-income countries...
Objective: To compare low dose sublingual misoprostol with the standard 10 IU of intramuscular oxyto...
BackgroundA myriad of interventions exist to treat postpartum hemorrhage (PPH), ranging from uteroto...
Postpartum haemorrhage (PPH) remains a major cause of maternal deaths worldwide, and is estimated to...
In contemporary obstetrics, postpartum hemorrhage is one of the primary causes of maternal mortality...
International audienceOBJECTIVE: To evaluate the effectiveness and safety of misoprostol administere...
Objectives: To identify new and underutilized technologies that may assist in reducing maternal mort...
Ndola Prata, Karen Weidert Bixby Center for Population, Health and Sustainability, School of Public...
Background: Postpartum hemorrhage (PPH) is a major public health problem due to complications that h...